Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Covington
Healthtrust
Johnson and Johnson
Mallinckrodt
Teva
UBS
Queensland Health
Baxter

Generated: July 19, 2018

DrugPatentWatch Database Preview

Calcipotriene - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for calcipotriene and what is the scope of calcipotriene patent protection?

Calcipotriene
is the generic ingredient in three branded drugs marketed by Mayne Pharma, Glenmark Pharms, Tolmar, Leo Pharma As, Glenmark Pharms Inc, Fougera Pharms, G And W Labs Inc, Hi Tech Pharma, Novel Labs Inc, and Leo Pharm, and is included in twelve NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Calcipotriene has twenty-six patent family members in twelve countries.

There are twelve drug master file entries for calcipotriene. Fourteen suppliers are listed for this compound.
Pharmacology for calcipotriene
Ingredient-typeVitamin D
Drug ClassVitamin D Analog
Synonyms for calcipotriene
(1?,3?,5Z,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1,3,24-triol
(1|A,3|A,5E,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1,3,24-triol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,2E,4S)-4-Cyclopropyl-4-hydroxy-1-methyl-2-buten-1-yl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-cyclohexanediol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,1R)-4-cyclopropyl-4-hydroxy-1-methyl-but-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
(1R,3S,5Z)-5-[(2E)-2-[(1R,7aR)-1-[(E,2R,5S)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylenecyclohexane-1,3-diol
(1R,3S,5Z)-5-[(2E)-2-[(1R,7aR)-1-[(E,2R,5S)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
(1R,3S,5Z)-5-[(2E)-2-[(1R,7aR)-1-[(E,2R,5S)-5-cyclopropyl-5-oxidanyl-pent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol
(1R,3S,Z)-5-(2-((1R,7aR,E)-1-((2R,5S,E)-5-cyclopropyl-5-hydroxypent-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
(1S,3R,5Z,7E,22E,24S)-26,27-cyclo-9,10-secocholesta-5,7,10,22-tetraene-1,3,24-triol
(1S,3S,5E)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,2E,4S)-4-Cyclopropyl-4-hydroxy-1-methyl-2-buten-1-yl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-cyclohexanediol
(1S,3S,5Z)-5-[(2E)-2-[(1R,3aR,7aR)-1-[(E,2S)-5-Cyclopropyl-5-hydroxy-pent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol
(1S,5Z,7Z,17ALPHA,22E)-24-CYCLOPROPYL-9,10-SECOCHOLA-5,7,10,22-TETRAENE-1,3,24-TRIOL
(22E)-(24R)-1alpha,24-dihydroxy-26,27-cyclo-22,23-didehydro-20-epivitamin D3 / (22E)-(24R)-1alpha,24-dihydroxy-26,27-cyclo-22,23-didehydro-20-epicholecalciferol
(22E)-(24S)-1alpha,24-dihydroxy-26,27-cyclo-22,23-didehydrovitamin D3 / (22E)-(24S)-1alpha,24-dihydroxy-26,27-cyclo-22,23-didehydrocholecalciferol / Calcipotriol
(5E,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta,24-triol
(5E)-Calcipotriene
(5E)-Calcipotriol
(5Z,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta,24-triol
(5Z,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta,24-triol hydrate
(5Z,7E,22E)-(1S,3R,20S,24R)-26,27-cyclo-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,24-triol
(5Z,7E,22E)-(1S,3R,24S)-26,27-cyclo-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,24-triol
(5Z,7E,24S)-26,27-Cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1alpha,3beta,24-triol
(5Z)-5-[(2Z)-2-[1-[(E)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
1-ALPHA,24S-(OH)2-22-ENE-26,27-DEHYDROVITAMIN D3
1,24(OH)2-22-ene-24-cyclopropyl D3
1,3-Cyclohexanediol, 5-((2E)-2-((1R,3aS,7aR)-1-((1R,2E,4S)-4-cyclopropyl-4-hydroxy-1-methyl-2-buten-1-yl)octahydro-7a-methyl-4H-inden-4-ylidene)ethylidene)-4-methylene-, (1S,3S,5E)-
112828-00-9
112965-21-6
113082-99-8
143NQ3779B
147657-22-5
1s19
24207-EP2275420A1
24207-EP2295055A2
24207-EP2295416A2
24207-EP2298748A2
24207-EP2298764A1
24207-EP2298765A1
24207-EP2305640A2
24207-EP2305642A2
24207-EP2308861A1
24207-EP2311453A1
24207-EP2314590A1
5,6-trans-Calcipotriol
828C009
9,10-Secochola-5,7,10(19),22-tetraene-1,3,24-triol, 24-cyclopropyl-, (1alpha,3beta,5E,7E,22E,24S)-
9,10-Secochola-5,7,10(19),22-tetraene-1,3,24-triol, 24-cyclopropyl-, (1alpha,3beta,5Z,7E,22E,24S)-
9,10-Secochola-5,7,10(19),22-tetraene-1,3,24-triol, 24-cyclopropyl-, (1alpha,3beta,5Z,7E,22E)-
9,10-Secochola-5,7,10(19),22-tetraene-1,3,24-triol, 24-cyclopropyl-,(1-alpha,3-beta,5Z,7E,22E,24S)-
A802667
AB00698343-05
AC-4696
AC1NQZJ5
AC1NRC3V
AC1O455M
AC1O5L5S
AKOS005146500
AKOS015855239
AKOS024457248
AN-33413
BDBM50369964
BIDD:GT0282
BMS-181161
BRD-K56429665-001-03-9
Calcipotriene (USAN)
Calcipotriene [USAN]
CALCIPOTRIENE HYDRATE
Calcipotriol
Calcipotriol (JAN)
Calcipotriol hydrate
Calcipotriol, (5E)-
Calcipotriol, anhydrous
Calcipotriol, anhydrous impurity C [EP]
Calcipotriol, anhydrous specified impurity C [EP]
Calciptriol
Calciptriol, MC-903, Daivonex, Dovonex, Psorcutan
Calcitrene
CAS-112965-21-6
CCG-100949
CCRIS 7700
CHEBI:50749
CHEMBL1200666
CHEMBL1366876
CPD000466353
CS-0387
D01125
D01QUS
Daivonex
Daivonex (TN)
Davonex
DB02300
Divonex
Dovonex
Dovonex (TN)
DR002481
DSSTox_CID_26648
DSSTox_GSID_46648
DSSTox_RID_81793
DTXSID0046648
Epitope ID:114242
FT-0082647
GTPL2778
HE296778
HMS2051N11
HMS2089J08
HMS3269P03
HY-10001
LMST03020106
LMST03020107
LS-144707
LWQQLNNNIPYSNX-UROSTWAQSA-N
MC 903
MC-903
MC903
MFCD10567086
MLS000759467
MLS001424130
MolPort-035-765-674
NC00199
NCGC00167465-01
NCGC00167465-02
NCGC00167837-01
O763
PRI 2201
PRI 2205
PRI-2205
Psorcutan
PubChem18810
PubChem19334
QRA3492A7Q
RTC-020913
SCHEMBL1131595
SCHEMBL13044528
SCHEMBL17430783
SCHEMBL2131847
SCHEMBL2853
SCHEMBL9360339
SMR000466353
Sorilux
STF-115469
TC-020913
Tox21_112469
Tox21_112469_1
U-0267
UNII-143NQ3779B
UNII-QRA3492A7Q
W-5148
ZINC3921872
ZINC77285174

US Patents and Regulatory Information for calcipotriene

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms CALCIPOTRIENE calcipotriene SOLUTION;TOPICAL 078305-001 May 6, 2008 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glenmark Pharms CALCIPOTRIENE calcipotriene CREAM;TOPICAL 205772-001 Jun 9, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hi Tech Pharma CALCIPOTRIENE calcipotriene SOLUTION;TOPICAL 077579-001 Nov 19, 2009 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Tolmar CALCIPOTRIENE calcipotriene SOLUTION;TOPICAL 077029-001 Nov 20, 2009 AT RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for calcipotriene

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leo Pharm DOVONEX calcipotriene SOLUTION;TOPICAL 020611-001 Mar 3, 1997 ➤ Sign Up ➤ Sign Up
Leo Pharm DOVONEX calcipotriene SOLUTION;TOPICAL 020611-001 Mar 3, 1997 ➤ Sign Up ➤ Sign Up
Leo Pharma As DOVONEX calcipotriene CREAM;TOPICAL 020554-001 Jul 22, 1996 ➤ Sign Up ➤ Sign Up
Leo Pharm DOVONEX calcipotriene SOLUTION;TOPICAL 020611-001 Mar 3, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for calcipotriene

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,730,288 Mousse composition ➤ Sign Up
7,029,659 Mousse composition ➤ Sign Up
8,298,515 Vitamin formulation ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Fuji
Moodys
Cipla
Merck
Baxter
Teva
US Department of Justice
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.